What question did this study set out to answer?

This review focuses on the potential of prodrug-incorporated nanoparticles to improve targeted cancer therapy by enhancing drug solubility and reducing side effects.

July 1, 2026Open Access

Nanoparticulate Prodrug Delivery Systems in Targeted Cancer Therapy: Formulation Approaches, Activation Mechanisms, and Translational Prospects

View Full Paper

Ask AI

Bookmark

Authors

MPMrs. T. Arokkiya Angel*, Mr. A. N. Venkatesh1, Ms. P. Priya2

Discussion

Member takes

Overview

Review examines prodrug nanoparticles' effectiveness in delivering cancer treatments, highlighting potential advancements.

Key Points

This review focuses on the potential of prodrug-incorporated nanoparticles to improve targeted cancer therapy by enhancing drug solubility and reducing side effects.
Comprehensive examination of prodrug nanoparticle designs and activation mechanisms.
Evaluation of various nanoparticle architectures and their applications in cancer treatment.
Analysis of preclinical and emerging clinical applications across several cancer types.
Prodrug-incorporated nanoparticles enhance drug delivery efficiency and tumor selectivity.
Stimuli-activated systems utilize biological cues for precise drug release at tumor sites.
Identified barriers include fabrication, biosafety, and regulatory challenges for widespread application.

Cite This Study

Mrs. T. Arokkiya Angel*, Mr. A. N. Venkatesh1, Ms. P. Priya2 (2026) studied this question.

synapsesocial.com/papers/6a44af895cd2549c8bc44815 https://doi.org/10.5281/zenodo.21037688

View Full Paper

Ask AI

Bookmark

July 1, 2026Open Access

Nanoparticulate Prodrug Delivery Systems in Targeted Cancer Therapy: Formulation Approaches, Activation Mechanisms, and Translational Prospects

View Full Paper

Ask AI

Bookmark

Authors

MPMrs. T. Arokkiya Angel*, Mr. A. N. Venkatesh1, Ms. P. Priya2

Discussion

Member takes

Overview

Review examines prodrug nanoparticles' effectiveness in delivering cancer treatments, highlighting potential advancements.

Key Points

This review focuses on the potential of prodrug-incorporated nanoparticles to improve targeted cancer therapy by enhancing drug solubility and reducing side effects.
Comprehensive examination of prodrug nanoparticle designs and activation mechanisms.
Evaluation of various nanoparticle architectures and their applications in cancer treatment.
Analysis of preclinical and emerging clinical applications across several cancer types.
Prodrug-incorporated nanoparticles enhance drug delivery efficiency and tumor selectivity.
Stimuli-activated systems utilize biological cues for precise drug release at tumor sites.
Identified barriers include fabrication, biosafety, and regulatory challenges for widespread application.

Cite This Study

Mrs. T. Arokkiya Angel*, Mr. A. N. Venkatesh1, Ms. P. Priya2 (2026) studied this question.

synapsesocial.com/papers/6a44af895cd2549c8bc44815 https://doi.org/10.5281/zenodo.21037688

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark